Helicobacter pylori is an aetiological factor for ischaemic heart disease: The case against

Digestive and Liver Disease

Volumn 32, Issue 1, 2000, Pages 65-68

  Cammarota, G ^a   Pasceri, V ^a   Gasbarrini, A ^a   Gasbarrini, G ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

Helicobacter pylori; Infections; Inflammation; Ischaemic heart disease

Indexed keywords

ATHEROSCLEROSIS; CHLAMYDOPHILA PNEUMONIAE; CYTOMEGALOVIRUS; DISEASE ASSOCIATION; GRAM NEGATIVE INFECTION; HELICOBACTER PYLORI; HERPES VIRUS; HUMAN; INFECTION; INFLAMMATION; ISCHEMIC HEART DISEASE; MEDICAL CARE; PREVALENCE; REVIEW;

EID: 0034070149     PISSN: 11258055     EISSN: None     Source Type: Journal    
DOI: 10.1016/s1590-8658(00)80047-x     Document Type: Review

References (35)

1. Scandinavian Simvastatin Survival Study Group. Randomised trial of cholesterol lowering in 4,444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 1994;344:1383-9.
2. Shepherd J, Cobbe SM, Ford I, Isles CG, Lorimer AR, MacFarlane PW, et al. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. N Engl J Med 1995;333:1301-7.
3. Breslow JL. Cardiovascular disease burden increases, NIH funding decreases. Nat Med 1997;3:600-1.
4. Braunwald E. Shattuck Lecture - cardiovascular medicine at the turn of the millennium: triumphs, concerns, and opportunities. N Engl J Med 1997;337:1360-9.
5. Ridker PM, Cushman M, Stampfer M, Tracy R, Hennekens CH. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 1997;336:973-9.
6. Patel P, Mendall MA, Carrington D, Strachan D, Leatham E, Molineaux N, et al. Association of Helicobacter pylori and Chlamydia pneumoniae infections with coronary heart disease and cardiovascular risk factors. Br Med J 1995;311:711-4.
7. Liuzzo G, Luigi M, Biasucci L, Pepys M. The prognostic value of C-reactive protein and serum amyloid A protein in severe unstable angina. N Engl J Med 1994;331:417-24.
8. Thompson S, Kienast J, Pyke S, Heverkate F, Van de Loo J. Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. N Engl J Med 1995;332:635-41.
9. Libby P, Egan D, Skarlatos S. Roles of infectious agents in atherosclerosis and re-stenosis: an assessment of the evidence and need for future research. Circulation 1997;96:4095-103.
10. Patel P, Carrington D, Strachan DP, Leatham E, Goggin P, Northfield T, et al. Fibrinogen: a link between chronic infection and coronary heart disease. Lancet 1994;343:1634-5.
11. Torgano G, Cosentini R, Mandelli C, Perondi R, Blasi F, Bertinieri G, et al. Treatment of Helicobacter pylori and Chlamydia pneumoniae infections decreases fibrinogen plasma level in patients with ischemic heart disease. Circulation 1999;99:1555-9.
12. Parente F, Maconi G, Imbesi V, Sangaletti O, Poggio M, Rossi E, et al. Helicobacter pylori infection and coagulation in healthy people. Br Med J 1997;314:1318-9.
13. Pasceri V, Cammarota G, Patti G, Cuoco L, Gasbarrini A, Grillo RL, et al. Association of virulent Helicobacter pylori strains with ischaemic heart disease. Circulation 1998;97:1675-9.
14. Danesh J, Collins R, Peto R. Chronic infections and coronary heart disease: is there a link? Lancet 1997;350:430-6.
15. Cammarota G, Pasceri V, Papa A, Cianci R, Gasbarrini A, Fedeli P, et al. Helicobacter pylori infection and ischaemic heart disease. Ital J Gastroenterol Hepatol 1998;30(Suppl.3):S304-6.
16. Feldman RA. Confounding factors in observational and intervention studies. Ital J Gastroenterol Hepatol 1998;30(Suppl 3):S248-53.
17. Kuvin JT, Kimmelstiel CD. Infectious causes of atherosclerosis. Am Heart J 1999;137:216-26.
18. Wong YK, Gallagher PJ, Ward ME. Chlamydia pneumoniae and atherosclerosis. Heart 1999;31:232-8.
19. Folsom AR, Nieto FJ, Sorlie P, Chambless LE, Graham DY. Helicobacter pylori seropositivity and coronary heart disease incidence. Atherosclerosis Risk In Communities (ARIC) Study Investigators. Circulation 1998;98:845-50.
20. Wald NJ, Law MR, Morris JK, Bagnall AM. Helicobacter pylori infection and mortality from ischaemic heart disease: negative result from a large, prospective study. Br Med J 1997;315:1199-201.
21. Strachan DP, Mendall MA, Carrington D, Butland BK, Yarnell JWG, Sweetnam PM, et al. Relation of Helicobacter pylori infection to 13-year mortality and incident ischemic heart disease in the Caerphilly prospective heart disease study. Circulation 1998;98:1286-90.
22. Peek RM, Miller GG, Tham KT, Perez-Perez GI, Zhao X, Atherton JC, et al. Heightened inflammatory response and cytokine expression in vivo to cagA+ Helicobacter pylori strains. Lab Invest 1995;73:760-70.
23. Ossewaarde JM, Feskens EJ, De Vries A, Valinga CE, Kromhout D. Chlamydia pneumoniae is a risk factor for coronary heart disease in symptom-free elderly men, but Helicobacter pylori and Cytomegalovirus are not. Epidemiol Infect 1998;120:93-9.
24. Danesh J, Wong Y, Ward M, Muir J. Chronic infection with Helicobacter pylori, Chlamydia pneumoniae, or Cytomegalovirus: population based study of coronary heart disease. Heart 1999;81:245-7.
25. Anderson JL, Carlquist JF, Muhlestein JB, Horne BD, Elmer SP. Evaluation of C-reactive protein, an inflammatory marker, and infectious serology as risk factors for coronary artery disease and myocardial infarction. J Am Coll Cardiol 1998;32:35-41.
26. Liuzzo G, Biasucci L, Gallimore JR, Grillo RL, Rebuzzi AG, Pepys MB, et al. The prognostic value of C-reactive protein in severe unstable angina. N Engl J Med 1994;331:417-24.
27. Caligiuri G, Liuzzo G, Biasucci L, Maseri A. Immune system activation follows inflammation in unstable angina: pathogenetic implications. J Am Coll Cardiol 1998;32:1295-304.
28. Gurfinkel E, Bozovich G. Chlamydia pneumoniae: inflammation and instability of the atherosclerotic plaque. Atherosclerosis 1998;140(Suppl 1):S31-5.
29. Ossei Gerning N, Moayyedi P, Smith S, Braunholtz D, Wilson JI, Axon AT, Grant PJ. Helicobacler pylori infection is related to atheroma in patients undergoing coronary angiography. Cardiovasc Res 1997;35:120-4.
30. Murray LJ, Bamford KB, O'Reilly DP, McCrum EE, Evans AE. Helicobacter pylori infection: relation with cardiovascular risk factors, ischaemic heart disease, and social class. Br Heart J 1995;74:497-501.
31. Mendall MA, Goggin PM, Molineaux N, Levy J, Toosy T, Strachan D, et al. Relation of Helicobacter pylori infection and coronary heart disease. Br Heart J 1994;71:437-9.
32. Whincup PH, Mendall MA, Perry IJ, Strachan DP, Walker M. Prospective relations between Helicobacter pylori infection, coronary heart disease and stroke in middle aged men. Heart 1996;75:568-72.
33. Niemelä S, Karttunen T, Korhonen T, Läärä E, Karttunen R, Ikäheimo M, et al. Could Helicobacter pylori infection increase the risk of coronary heart disease by modifying serum lipid concentrations? Heart 1996;75:573-5.
34. Rathbone B, Martin D, Stephens J, Thompson JR, Samani NJ. Helicobacter pylori seropositivity in subjects with acute myocardial infarction. Heart 1996;76:308-11.
35. McDonagh TA, Woodward M, Morrison CE, McMurray JJV, Tundstall-Pedoe H, Lowe GDO, et al. Helicobacter pylori infection and coronary heart disease in the North Glasgow MONICA population. Eur Heart J 1997;18:1257-60.